- Bahn RS, Burch HB, Cooper DS, et al; American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593–646. doi:10.1089/thy.2010.0417.
- Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–499. doi:10.1210/jcem.87.2.8182.
- Kravets I. Hyperthyroidism: diagnosis and treatment. Am Fam Physician. 2016;93(5):363–370.
- Biondi B, Cooper DS. Subclinical hyperthyroidism. N Engl J Med. 2018;378(25):2411–2419. doi:10.1056/NEJMcp1709318.
- Brent GA. Clinical practice. Graves’ disease. N Engl J Med. 2008;358(24):2594–2605. doi:10.1056/NEJMcp0801880.
- Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the heart. Methodist Debakey Cardiovasc J. 2017;13(2):60–63. doi:10.14797/mdcj-13-2-60.
- Healthcare Cost and Utilization Project. Introduction to the HCUP National Inpatient Sample (NIS). the National (Nationwide) Inpatient Sample database documentation. Rockville, MD: Agency for Healthcare Research and Quality; 2018. https://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2018.jsp. Accessed February 10, 2021.
- Houchens R, Ross D, Elixhauser A, Jiang J. 2014. Nationwide Inpatient Sample (NIS) Redesign Final Report. US Agency for Healthcare Research and Quality; 2014. http://www.hcup-us.ahrq.gov/reports/methods/methods.jsp.
- US Census Bureau, Population Division. Table 1. Intercensal estimates of the resident population by sex and age for the United States: April 1, 2000 to July 1, 2010 (US-EST00INT-01). https://www2.census.gov/programs-surveys/popest/tables/2000-2010/intercensal/national/us-est00int-01.xls. Accessed July 4, 2021
- US Census Bureau, Population Division. Annual estimates of the resident population for selected age groups by sex for the United States: April 1, 2010 to July 1, 2019 (NC-EST2019-AGESEX). https://www2.census.gov/programs-surveys/popest/tables/2010-2019/national/asrh/nc-est2019-agesex.xlsx. Accessed July 4, 2021
- Sundararajan V, Quan H, Halfon P, et al; International Methodology Consortium for Coded Health Information (IMECCHI). Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care. 2007;45(12):1210–1215. doi:10.1097/MLR.0b013e3181484347.
- Agency for Healthcare Research and Quality. HCUP Cost-to-Charge Ratio (CCR). 2008–2018. https://www.hcup-us.ahrq.gov/db/ccr/costtocharge.jsp. Accessed February 10, 2021.
- Dunn A, Grosse SD, Zuvekas SH. Adjusting health expenditures for inflation: A review of measures for health services research in the United States. Health Serv Res. 2018;53(1):175–196. doi:10.1111/1475-6773.12612.
- Barrett M, Coffey R, Levit K. Population denominator data sources and data for use with the HCUP databases (updated with 2019 population data) [2020 HCUP Methods Series Report # 2020-02]. US Agency for Healthcare Research and Quality2020. www.hcup-us.ahrq.gov/reports/methods.jsp.
- Cappellani D, Papini P, Di Certo AM, et al. Duration of exposure to thyrotoxicosis increases mortality of compromised AIT patients: the role of early thyroidectomy. J Clin Endocrinol Metab. 2020;105(9):dgaa464. doi:10.1210/clinem/dgaa464.
- Mitchell JE, Hellkamp AS, Mark DB, et al. Thyroid function in heart failure and impact on mortality. JACC Heart Fail. 2013;1(1):48–55. doi:10.1016/j.jchf.2012.10.004.
- Siu CW, Yeung CY, Lau CP, Kung AW, Tse HF. Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart. 2007;93(4):483–487. doi:10.1136/hrt.2006.100628.
- Iglesias P, Acosta M, Sánchez R, Fernández-Reyes MJ, Mon C, Díez JJ. Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function. Clin Endocrinol (Oxf). 2005;63(1):66–72. doi:10.1111/j.1365-2265.2005.02301.x.
- Small D, Gibbons W, Levy RD, de Lucas P, Gregory W, Cosio MG. Exertional dyspnea and ventilation in hyperthyroidism. Chest. 1992;101(5):1268–1273. doi:10.1378/chest.101.5.1268.
- McElvaney GN, Wilcox PG, Fairbarn MS, et al. Respiratory muscle weakness and dyspnea in thyrotoxic patients. Am Rev Respir Dis. 1990;141(5 Pt 1):1221–1227. doi:10.1164/ajrccm/141.5_Pt_1.1221.
- Marvisi M, Zambrelli P, Brianti M, Civardi G, Lampugnani R, Delsignore R. Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. Eur J Intern Med. 2006;17(4):267–271. doi:10.1016/j.ejim.2005.11.023.
- Spitaleri G, Lupón J, Domingo M, et al. Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018. Sci Rep. 2021;11(1):732. doi:10.1038/s41598-020-79926-3.
- Anguita Sánchez M, Bonilla Palomas JL, García Márquez M, Bernal Sobrino JL, Elola Somoza FJ, Marín Ortuño F. Temporal trends in hospitalization and in-hospital mortality rates due to heart failure by age and sex in Spain (2003-2018). Rev Esp Cardiol (Engl Ed). 2021;74(11):993–996. doi:10.1016/j.rec.2021.04.017.
- Rodríguez-Mañero M, Bertomeu-González V, Cordero A, et al. Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years. Rev Port Cardiol. 2013;32(2):103–109. doi:10.1016/j.repc.2012.06.011.
- Brito JP, Schilz S, Singh Ospina N, et al. Antithyroid drugs—the most common treatment for Graves’ disease in the United States: a nationwide population-based study. Thyroid. 2016;26(8):1144–1145. doi:10.1089/thy.2016.0222.
- Burch HB, Burman KD, Cooper DS. A 2011 survey of clinical practice patterns in the management of Graves’ disease. J Clin Endocrinol Metab. 2012;97(12):4549–4558. doi:10.1210/jc.2012-2802.
- Brooks T, Roygardner L, Artiga S, Pham O, Dolan R. Medicaid and CHIP Eligibility, Enrollment, and Cost Sharing Policies as of January 2019: Findings from a 50-State Survey. San Francisco: Kaiser Family Foundation; 2019.
- Rivas AM, Larumbe E, Thavaraputta S, Juarez E, Adiga A, Lado-Abeal J. Unfavorable socioeconomic factors underlie high rates of hospitalization for complicated thyrotoxicosis in some regions of the United States. Thyroid. 2019;29(1):27–35. doi:10.1089/thy.2018.0353.
- McWilliams JM. Health consequences of uninsurance among adults in the United States: recent evidence and implications. Milbank Q. 2009;87(2):443–494. doi:10.1111/j.1468-0009.2009.00564.x.
- Allen H, Gordon SH, Lee D, Bhanja A, Sommers BD. Comparison of utilization, costs, and quality of Medicaid vs subsidized private health insurance for low-income adults. JAMA Netw Open. 2021;4(1):e2032669. doi:10.1001/jamanetworkopen.2020.32669.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 6
Original Research
A decade of hospitalizations for hyperthyroidism in the US
Hafeez Shakaa Department of Internal Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, IllinoisCorrespondence[email protected]
https://orcid.org/0000-0002-9456-4581
, MDhttps://orcid.org/0000-0002-9456-4581, , MD, , MD, , MD, , MD & , MD